Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

Share Price is delayed by 15 minutes
Get Live Data
22.50    0.10 (0.44%)
Bid:
22.00
Ask:
23.00
Spread: 1.00 (4.545%)
Market Cap: £234.54m
SCLP Live PriceLast checked at - London Stock Exchange

Intraday Scancell Holdings Share Chart

Scancell Holdings News

LONDON MARKET MIDDAY: Stocks up, China warns on British Steel dispute
14 Apr 2025

LONDON MARKET MIDDAY: Stocks up, China warns on British Steel dispute

(Alliance News) - Stock prices in London were in the green at midday on Monday, while Beijing has warned the UK against "politicising" an unfolding sp...

AIM WINNERS & LOSERS: Scancell in partnership with NHS 'Launch Pad'
14 Apr 2025

AIM WINNERS & LOSERS: Scancell in partnership with NHS 'Launch Pad'

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday.

IN BRIEF: Scancell hurt by revaluation of derivative liability loss
30 Jan 2025

IN BRIEF: Scancell hurt by revaluation of derivative liability loss

Scancell Holdings PLC - Oxford, UK-based pharmaceutical firm - Pretax loss multiplies to GBP13.8 million in the six months to October 31 from GBP3.6 m...

Scancell encouraged by early results in cancer vaccine trial
9 Jan 2025

Scancell encouraged by early results in cancer vaccine trial

(Alliance News) - Scancell Holdings PLC on Thursday said its cancer vaccine had achieved early validation for clinical use.

IN BRIEF: Scancell funded deep into 2026 as raises GBP10 million
6 Dec 2024

IN BRIEF: Scancell funded deep into 2026 as raises GBP10 million

Scancell Holdings PLC - Oxford, England-based developer of immunotherapies - Raises GBP10.3 million from the placing and direct subscription of 97.7 m...

Scancell announces promising findings from cancer drug trial
18 Nov 2024

Scancell announces promising findings from cancer drug trial

(Alliance News) - Scancell Holdings PLC on Monday reported positive data from an ongoing trial on patients receiving a treatment combination for advan...

EXECUTIVE CHANGES: New Scancell, Nanoco and LPA CEOs; Coral CEO exits
26 Oct 2024

EXECUTIVE CHANGES: New Scancell, Nanoco and LPA CEOs; Coral CEO exits

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced this week and not separately reported by...